AT
Ashutosh Tiwari
Styx Biotechnologies, Post Graduate Institute of Medical Education and Research, All India Institute of Medical Sciences, Translational Health Science and Technology Institute
0000-0003-3404-8881
Employment
-
Styx Biotechnologies CEO2025 - Present
-
Styx Biotechnologies Co-founder & CSO2021 - 2025
-
Post Graduate Institute of Medical Education and Research Assistant Professor2015 - 2020
-
Translational Health Science and Technology Institute Investigator, Scientist C2011 - 2015
Education
-
All India Institute of Medical Sciences PhD2003 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements Save
- Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. Save
- Enhancement of mitochondrial function fosters B cell immune memory Save
- Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis Save
- Isolation and Characterization of Cross-Neutralizing Human Anti-V3 Single-Chain Variable Fragments (scFvs) Against HIV-1 from an Antigen Preselected Phage Library Save
- Serodiagnostic evaluation of recombinant CdtB of S. Typhi as a potential candidate for acute typhoid. Save
- Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins. Save
- Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals. Save
- A repertoire of high-affinity monoclonal antibodies specific to S. typhi: as potential candidate for improved typhoid diagnostic Save
- Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics Save